Dietary Lipid Sources and Lysolecithin Modulate Growth, Lipid Metabolism, Hepatopancreatic Health, and Intestinal Microbiota in Macrobrachium rosenbergii.
4 affiliations
- 1School of Life Sciences Huzhou Normal University Huzhou China.
- 2International Institute of Aquaculture and Aquatic Sciences Universiti Putra Malaysia Batu 7, Jalan Kemang 6, Teluk Kemang, Si Rusa Port Dickson 71050 Negeri Sembilan Malaysia upm.edu.my.
- 3Linyi Zhengnengliang Biological Co., Ltd. Linyi China.
- 4Department of Aquaculture Faculty of Agriculture Universiti Putra Malaysia Serdang 43400 Malaysia upm.edu.my.
Abstract
This study evaluated the effects of dietary lipid sources and lysolecithin (LL) supplementation on the growth performance, lipid metabolism, hepatopancreatic histology, and intestinal microbiota of Macrobrachium rosenbergii. A 56-day feeding trial was conducted using six isonitrogenous diets containing fish oil (FO), soybean oil (SO), or a 1:1 FO-SO blend (mixed oil [MO]), and each supplemented with or without 0.5% LL. Results indicated a significant interaction between dietary lipid sources and LL supplementation on growth performance (p < 0.05). The MO diet supplemented with LL yielded the highest growth rates, while LL supplementation significantly improved feed efficiency (p < 0.05). Regarding histological status, the dietary SO treatment induced a significant increase in hepatopancreatic lipid deposition (p < 0.0001) and histological alterations, while LL supplementation reduced lipid deposition and improved hepatopancreatic morphology. Dietary lipid source significantly affected muscle n-3 polyunsaturated fatty acids (PUFAs; p < 0.01). However, a significant interaction between dietary lipid source and LL supplementation was observed specifically for hepatopancreatic total n-3 PUFA (p = 0.0053). Gene expression analysis confirmed that LL modulates lipid metabolism in a source-dependent manner, upregulating fatty acid oxidation pathways (Pparα and Cpt1) in FO groups while influencing synthesis pathways (FAS) in SO groups (p < 0.05). Furthermore, LL supplementation significantly altered the composition of intestinal microbiota, specifically enriching beneficial bacterial genera in dietary SO-treatment (p < 0.05). In conclusion, the dietary treatment combining MOs and LL showed beneficial effects on growth performance, lipid metabolism, and hepatopancreatic health in M. rosenbergii.
Related
- Comprehensive transcriptome-wide characterisation of hepatopancreas in response to acute low-temperature stress in Macrobrachium rosenbergii
- Response of broiler chickens fed low-energy diets to increase levels of lysolecithin: linking growth performance with lipid metabolism gene expression, gut microbial modulation, intestinal morphology, and economic efficiency.
- YOLOv11-Pose-Based Tracking Reveals Neuropeptide F Regulation of Agonistic Behavior in Macrobrachium rosenbergii.
- Integrated transcriptomic and proteomic analyses of the mechanisms of Citrobacter freundii–induced ‘‘water bubble disease’’ in Macrobrachium rosenbergii
- Effects of Long-Term Salinity Exposure on Growth, Survival, Hepatopancreatic Health, and Intestinal Microbiota in Juvenile Chinese Mitten Crabs (Eriocheir japonica sinensis).
BibTeX
@article{qiu2026dietary,
title = {{Dietary Lipid Sources and Lysolecithin Modulate Growth, Lipid Metabolism, Hepatopancreatic Health, and Intestinal Microbiota in Macrobrachium rosenbergii.}},
author = {Zongsheng Qiu and Xinyi Wei and Jianle Yang and Yuqiang Wei and Shasha Liu and Jianhua Zhao and Qiyou Xu and Clement R de Cruz},
journal = {Aquaculture nutrition},
year = {2026},
month = oct,
doi = {10.1155/anu/8067288},
url = {https://europepmc.org/article/MED/42952995},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dietary Lipid Sources and Lysolecithin Modulate Growth, Lipid Metabolism, Hepatopancreatic Health, and Intestinal Microbiota in Macrobrachium rosenbergii.
AU - Zongsheng Qiu
AU - Xinyi Wei
AU - Jianle Yang
AU - Yuqiang Wei
AU - Shasha Liu
AU - Jianhua Zhao
AU - Qiyou Xu
AU - Clement R de Cruz
PY - 2026
DA - 2026/10/27
JO - Aquaculture nutrition
DO - 10.1155/anu/8067288
UR - https://europepmc.org/article/MED/42952995
AB - This study evaluated the effects of dietary lipid sources and lysolecithin (LL) supplementation on the growth performance, lipid metabolism, hepatopancreatic histology, and intestinal microbiota of Macrobrachium rosenbergii. A 56-day feeding trial was conducted using six isonitrogenous diets containing fish oil (FO), soybean oil (SO), or a 1:1 FO-SO blend (mixed oil [MO]), and each supplemented with or without 0.5% LL. Results indicated a significant interaction between dietary lipid sources and LL supplementation on growth performance (p < 0.05). The MO diet supplemented with LL yielded the highest growth rates, while LL supplementation significantly improved feed efficiency (p < 0.05). Regarding histological status, the dietary SO treatment induced a significant increase in hepatopancreatic lipid deposition (p < 0.0001) and histological alterations, while LL supplementation reduced lipid deposition and improved hepatopancreatic morphology. Dietary lipid source significantly affected muscle n-3 polyunsaturated fatty acids (PUFAs; p < 0.01). However, a significant interaction between dietary lipid source and LL supplementation was observed specifically for hepatopancreatic total n-3 PUFA (p = 0.0053). Gene expression analysis confirmed that LL modulates lipid metabolism in a source-dependent manner, upregulating fatty acid oxidation pathways (Pparα and Cpt1) in FO groups while influencing synthesis pathways (FAS) in SO groups (p < 0.05). Furthermore, LL supplementation significantly altered the composition of intestinal microbiota, specifically enriching beneficial bacterial genera in dietary SO-treatment (p < 0.05). In conclusion, the dietary treatment combining MOs and LL showed beneficial effects on growth performance, lipid metabolism, and hepatopancreatic health in M. rosenbergii.
SN - 1353-5773
SN - 1365-2095
ER -